Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 554 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Generic Eribulin January 12, 2024 Prostate cancer: Lessons Learned from My Breast Cancer June 23, 2021 Breast Cancer Survivor’s Family Designs a Holiday Light Show in Her... December 15, 2020 New Device Could “Hear” Stiffening of Extracellular Matrix to Determine Where... April 2, 2020 Load more HOT NEWS FDA Approves Amivantamab and Hyaluronidase-lpuj for Subcutaneous Injection £82,000 of Donations Pour in for Mom with Incurable Cancer to... Oncology Research Rebounds from Pandemic Low, but Shows Cancer Patients Need... Reused, Reheated Cooking Oil May Trigger Breast Cancer Progression, Metastasis
